Mature red cells develop from hemopoietic stem cells in the adult bone marrow. The production of red blood cells is primarily controlled by the hormone erythropoietin (Epo). Previously we had identified that the protein Lyn must be present inside primitive red blood cells for Epo to stimulate them to become mature functional cells. We will determine the role of several molecules that interact with Lyn including Cbp, Liar and LACM, towards apects of red blood cell development.
Defining The Role And Contribution Of Cdc37 To Signal Transduction And Tumourigenesis By Src-family Kinases
Funder
National Health and Medical Research Council
Funding Amount
$411,430.00
Summary
Cells respond to extracellular stimuli, such as growth factors and hormones, by activating intracellular networks of signaling molecules. It is the activation of these signaling networks that is ultimately responsible for mediating the biological responses of cells to extracellular stimuli (e.g. insulin stimulating glucose metabolism by cells). Members of the Src-family of tyrosine kinases are paramount among signaling molecules, as they are able to directly initiate the activation of a cascade ....Cells respond to extracellular stimuli, such as growth factors and hormones, by activating intracellular networks of signaling molecules. It is the activation of these signaling networks that is ultimately responsible for mediating the biological responses of cells to extracellular stimuli (e.g. insulin stimulating glucose metabolism by cells). Members of the Src-family of tyrosine kinases are paramount among signaling molecules, as they are able to directly initiate the activation of a cascade of signaling networks that regulate the activity of the cell. Significantly though, the inappropriate activation of Src-family kinases has been implicated in the development of cancer, particularly breast and colon cancer, in humans. To fulfill their signaling functions however, Src-family kinases must first be folded into an active conformation upon their synthesis in the cell then be maintained in this conformation. Although previous studies, including our own, have implicated a class of proteins called molecular chaperones in this process, little is known about how the folding of Src-family kinases by these proteins is achieved and regulated. The overall aim of this study is to determine how the folding of Hck, one member of the Src-family of tyrosine kinases, into a conformation that enables it to participate in signaling networks is achieved and regulated. It is expected that the results from this study will provide significant new insight into how this process might influence the ability of cells to respond to extracellular stimuli and potentially contribute to the conversion of a normal cell into one with tumourigenic properties. Findings from this project may be particularly important in the context of human cancer. A better knowledge of how the signaling activity of Src-family kinases is regulated by molecular chaperones might provide a new avenue of investigation for the identification of novel chemotherapeutic agents.Read moreRead less
Escape From BRAF-induced Human Melanocyte Senescence In The Genesis Of Melanoma
Funder
National Health and Medical Research Council
Funding Amount
$601,776.00
Summary
Melanoma is the most lethal form of skin cancer and activation of the MAPK growth pathway is a crucial step in the initiation of this cancer, but alone is insufficient, as most melanocytes with active MAPK exist in a growth arrested state. The mechanisms responsible for arresting melanocytes in the presence of active MAPK will be investigated. This project will discover why some melanocytes develop into melanomas whereas most do not.
The Regulation Of 14-3-3 Protein Function By Post-translational Modification
Funder
National Health and Medical Research Council
Funding Amount
$212,036.00
Summary
The cells of our body have control mechanisms that prevent them from growing abnormally. However, when cells become cancerous they escape the normal checks and controls and are able to survive, divide and grow uncontrollably. In the last decade the molecular basis of several of the control mechanisms involved in preventing cancerous growth have been uncovered. However, our understanding is far from complete and recent research reports suggest that we have thus far overlooked a whole level of reg ....The cells of our body have control mechanisms that prevent them from growing abnormally. However, when cells become cancerous they escape the normal checks and controls and are able to survive, divide and grow uncontrollably. In the last decade the molecular basis of several of the control mechanisms involved in preventing cancerous growth have been uncovered. However, our understanding is far from complete and recent research reports suggest that we have thus far overlooked a whole level of regulation of cell growth control. Signals that instruct a normal cell to divide are propogated by pathways of interacting molecules within the cell. These pathways are regulated by switch mechanisms that either modify the interacting molecules, thereby inactivating their activity or by controlling when and where the molecules are allowed to interact. This spatial and temporal control mechanism is mediated by a family of specialised molecules, called 14-3-3 proteins. Recent research indicates that the function of these 14-3-3 proteins is also tightly controlled, although as yet we don't understand how. This research proposal attempts to discover the molecular mechanism of regulation of 14-3-3 function. An understanding of this process may provide new molecular targets for the development of therapeutics against cancer.Read moreRead less
Characterisation Of Novel CDKL5 Targets: Implications For Rett Syndrome And Related Neurodevelopmental Disorders.
Funder
National Health and Medical Research Council
Funding Amount
$421,977.00
Summary
Rett syndrome (RTT) is the second most common cause of severe mental retardation in girls and women. Although two genes (MECP2 and CDKL5) responsible for RTT have been identified, we still do not understand how these genes affect brain function. The focus of this research project is to identify which proteins are controlled by CDKL5, with the express hope that a better understanding of these processes will allow us to design specfic therapies for this untreatable devasting disorder.
Inhibition Of Nef-activated Src-family Kinases By CHK
Funder
National Health and Medical Research Council
Funding Amount
$514,307.00
Summary
HIV hijacks infected blood cells to produce its own proteins. Nef is one of these proteins and Nef alone is sufficient to cause an AIDS-like disease. Recently, we discovered that a protein called CHK can inhibit Nef. Our research will determine how CHK inhibits Nef and test the feasibility of drugs based on CHK. Such drugs would slow AIDS progression, assisting conventional therapies and patients' immune systems to combat the infection, leading to longer, healthier, more productive lives.
Recent evidence suggests that the Siah proteins are involved in sensing low oxygen levels in cells, and subsequently activating processes to help the cell survive under these conditions. Low oxygen conditions occur in cancer and sites of inflammation, suggesting that inhibiting Siah may improve patient outcomes in diseases such as cancer and arthritis. We aim to perform a high throughput screen for drugs that inhibit Siah protein function and to test these in cancer cells.
Structural Characterisation Of SNARE Protein Complexes Involved In Insulin-regulated Glucose Transport
Funder
National Health and Medical Research Council
Funding Amount
$320,803.00
Summary
Insulin-regulated glucose transportation is defective in type 2 diabetes, a disease that is a major health problem worldwide and in some cases can lead to death. The aim of this work is to investigate the molecular structure and function of proteins critical to the transportation and delivery of glucose to muscle and fat cells, which will lead to the validation of new therapeutic targets and the development of new treatments for diabetes.